# Boswellia carterii

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/boswellia-carterii
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-19
**Evidence Score:** 8 / 10
**Category:** Middle Eastern
**Also Known As:** Boswellia carterii, Frankincense, Olibanum, Indian Frankincense, Boswellic Acid Extract, Ru Xiang, Salai Guggul, Arabian Frankincense

## Overview

Boswellia carterii is a frankincense species containing boswellic acids that modulate immune responses by shifting cytokine production from inflammatory TH1 to [anti-inflammatory](/ingredients/condition/inflammation) TH2 patterns. Research shows potential anti-leukemia activity with selective cytotoxicity against cancer cell lines while sparing normal cells.

## Health Benefits

• May modulate immune response by inhibiting TH1 cytokines (IL-2, IFN-γ) and promoting TH2 cytokines (IL-4, IL-10) - based on in vitro murine studies only
• Shows potential anti-leukemia activity with selective cytotoxicity against leukemia cell lines (IC50 selectivity indexes 1.75-2.68) - preliminary in vitro evidence only
• Demonstrates antibacterial effects and enhanced phagocytosis (79.7% vs. 57.75% control) against nosocomial bacteria - based on in vitro studies (PMID: 36284973)
• May induce cancer cell apoptosis through [mitochondrial](/ingredients/condition/energy) pathway (285.4% increase in late apoptosis) - in vitro evidence only
• Traditional use for [inflammatory](/ingredients/condition/inflammation) arthritis in Chinese and Indian herbal systems - no clinical trials available

## Mechanism of Action

Boswellic acids in Boswellia carterii inhibit pro-inflammatory TH1 cytokines including interleukin-2 and interferon-gamma while promoting [anti-inflammatory](/ingredients/condition/inflammation) TH2 cytokines like IL-4 and IL-10. The compounds demonstrate selective cytotoxicity against leukemia cell lines through mechanisms that preferentially target cancer cells over healthy cells.

## Clinical Summary

Current evidence is limited to in vitro murine studies demonstrating [immune modulation](/ingredients/condition/immune-support) effects on [cytokine](/ingredients/condition/inflammation) profiles. Preliminary cancer research shows selective cytotoxicity against leukemia cell lines with IC50 selectivity indexes ranging from 1.75 to 2.68, indicating moderate selectivity for cancer cells. No human clinical trials have been conducted to validate these preliminary findings. The evidence base requires significant expansion with human studies before therapeutic claims can be substantiated.

## Nutritional Profile

Boswellia carterii (Frankincense) is a resin-based ingredient with negligible macronutrient content in typical usage quantities. Primary bioactive compounds are pentacyclic triterpenic acids, dominated by boswellic acids at approximately 25-35% of total resin dry weight. Key identified compounds include: α-boswellic acid and β-boswellic acid (combined ~15-20% of resin), 11-keto-β-boswellic acid (KBA, ~5-8%), acetyl-11-keto-β-boswellic acid (AKBA, ~1-3%, considered most pharmacologically active), acetyl-α-boswellic acid (~3-5%), and acetyl-β-boswellic acid (~2-4%). Essential oil fraction constitutes approximately 5-9% of resin, containing monoterpenes (α-pinene ~50-70% of essential oil fraction), limonene (~3-5%), and p-cymene (~1-3%). Resin also contains polysaccharides (arabinogalactans, ~20-30% of resin), including arabinose and galactose units. Minor phenolic constituents include luteolin and quercetin derivatives at trace levels (<0.1%). Carbohydrate content from polysaccharide fraction is notable but bioavailability is low when resin is used in non-aqueous preparations. AKBA bioavailability is poor orally (<1% absorption) due to lipophilicity; phospholipid complexation has been shown to improve absorption approximately 3-fold. No significant vitamin or mineral content has been documented at typical culinary or therapeutic doses. Fiber content negligible in resin form. Protein content essentially absent.

## Dosage & Preparation

No clinically studied dosage ranges for Boswellia carterii in humans are available. In vitro studies used ethanol extracts in sesame oil for murine cells and methanolic extracts for cytotoxicity assays, but human dosing has not been established. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Safety data for Boswellia carterii is limited due to lack of human studies. As with other Boswellia species, potential side effects may include gastrointestinal upset, skin rash, or nausea. Given the immune-modulating properties, it may interact with immunosuppressive medications or affect [immune system](/ingredients/condition/immune-support) function. Pregnant and breastfeeding women should avoid use due to insufficient safety data.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses on Boswellia carterii were identified. Evidence is limited to in vitro studies including [immunomodulatory](/ingredients/condition/immune-support) effects on murine splenocytes (PMID: 15879017) and antibacterial activity (PMID: 36284973). All available research is preclinical, with no human dosing or safety data established.

## Historical & Cultural Context

Boswellia carterii resin (frankincense) has been included in traditional herbal formulas from Chinese and Indian systems for treating [inflammatory](/ingredients/condition/inflammation) arthritis. Historical use aligns with broader Boswellia species applications in these traditional medicine systems.

## Synergistic Combinations

Other Boswellia species, Turmeric, Ginger, White Willow Bark, Quercetin

## Frequently Asked Questions

### What are the active compounds in Boswellia carterii?

Boswellia carterii contains boswellic acids as its primary bioactive compounds. These compounds are responsible for the immune-modulating and potential anti-cancer effects observed in laboratory studies.

### How does Boswellia carterii affect the immune system?

Boswellia carterii modulates immune response by inhibiting inflammatory TH1 cytokines (IL-2, IFN-γ) and promoting anti-inflammatory TH2 cytokines (IL-4, IL-10). This shift from TH1 to TH2 dominance may reduce inflammatory responses, though this has only been demonstrated in laboratory studies.

### Is there evidence for Boswellia carterii's anti-cancer effects?

Preliminary laboratory studies show Boswellia carterii has selective cytotoxicity against leukemia cell lines with IC50 selectivity indexes of 1.75-2.68. However, this evidence is very early-stage and limited to cell culture studies with no human trials conducted.

### What's the difference between Boswellia carterii and Boswellia serrata?

Boswellia carterii is traditionally used in Unani medicine and shows specific immune-modulating properties in laboratory studies. Boswellia serrata is more commonly studied for joint health and has more extensive clinical research, though both species contain boswellic acids as active compounds.

### Are there any side effects of Boswellia carterii supplements?

Specific side effect data for Boswellia carterii is limited due to lack of human studies. Based on related Boswellia species, potential side effects may include digestive upset, skin reactions, or nausea, though comprehensive safety profiles have not been established.

### What is the most bioavailable form of Boswellia carterii, and how does extraction method affect its potency?

Standardized extracts of Boswellia carterii, particularly those concentrated for boswellic acids (the primary active compounds), generally offer superior bioavailability compared to raw gum resin. Extraction methods using organic solvents or supercritical CO2 can yield higher concentrations of boswellic acids, though standardization levels vary significantly between manufacturers. Enteric-coated or lipid-based formulations may further enhance absorption of these lipophilic compounds in the small intestine.

### Who should avoid Boswellia carterii supplementation, and are there specific populations at higher risk?

Individuals with bleeding disorders or those taking anticoagulant medications should consult healthcare providers before use, as preliminary evidence suggests potential antiplatelet activity. Pregnant and nursing women should avoid supplementation due to insufficient safety data in these populations. People with a history of severe allergic reactions to resins or other Boswellia species should exercise caution, as cross-reactivity is possible.

### How does the quality and sourcing of Boswellia carterii affect its therapeutic efficacy in supplements?

Boswellia carterii sourced from sustainable harvesting regions (primarily Oman and Yemen) and tested for boswellic acid content typically demonstrates more consistent bioactivity than unverified sources. Third-party testing for heavy metals, microbial contamination, and boswellic acid standardization (ideally 60% or higher) is essential, as wild-harvested material shows variable potency. Geographic origin and harvesting season can influence alkaloid and resin profiles, potentially affecting the immunomodulatory and anti-inflammatory effects observed in research studies.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*